Eguinto, Alea Gail .
HRN: 20-54-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFUROXIME 1.5GM (VIAL)
12/29/2022
01/04/2023
IVT
330mg
Q8
Pcap C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes